Probiotics for the Prevention of Beta Cell Autoimmunity in Children at Genetic Risk of Type 1 Diabetes—the PRODIA Study
2006 (English)In: Annals of the New York Academy of Sciences, ISSN 0077-8923, E-ISSN 1749-6632, Vol. 1079, 360-364 p.Article in journal (Refereed) Published
The final aim of the PRODIA study is to determine whether the use of probiotics during the first 6 months of life decreases the appearance of type 1 diabetes mellitus (T1DM)-associated autoantibodies in children with genetic risk for T1DM. A pilot study including 200 subjects was planned to show whether the use of probiotics during the first 6 months of life is safe and feasible. The prevalence of autoantibodies among the study subjects at 6, 12, and 24 months of age was at levels close to the expected and the clinical follow-up did not either indicate problems in the feasibility of the study.
Place, publisher, year, edition, pages
2006. Vol. 1079, 360-364 p.
type 1 diabetes, probiotics, autoantibodies
National CategoryMedical and Health Sciences
IdentifiersURN: urn:nbn:se:liu:diva-35923DOI: 10.1196/annals.1375.055ISI: 000243126100055Local ID: 29080OAI: oai:DiVA.org:liu-35923DiVA: diva2:256771